100.86 USD
-3.03 (-2.92%)
100.86 USD
0 (0%)
IRMD gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. IRMD gets an excellent profitability rating and is at the same time showing great financial health properties. IRMD has a decent growth rate and is not valued too expensively. These ratings could make IRMD a good candidate for quality investing.
1. Profitability
1.1 Basic Checks
- In the past year IRMD was profitable.
- In the past year IRMD had a positive cash flow from operations.
- IRMD had positive earnings in each of the past 5 years.
- Each year in the past 5 years IRMD had a positive operating cash flow.
1.2 Ratios
- IRMD's Return On Assets of 18.47% is amongst the best of the industry. IRMD outperforms 98.92% of its industry peers.
- IRMD has a better Return On Equity (21.54%) than 94.62% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 19.30%, IRMD belongs to the top of the industry, outperforming 97.31% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for IRMD is significantly above the industry average of 8.84%.
- The 3 year average ROIC (18.78%) for IRMD is below the current ROIC(19.30%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.47% | ||
| ROE | 21.54% | ||
| ROIC | 19.3% |
ROA(3y)17.74%
ROA(5y)13.28%
ROE(3y)21.21%
ROE(5y)15.76%
ROIC(3y)18.78%
ROIC(5y)N/A
1.3 Margins
- IRMD has a better Profit Margin (26.31%) than 95.70% of its industry peers.
- In the last couple of years the Profit Margin of IRMD has remained more or less at the same level.
- IRMD has a better Operating Margin (30.87%) than 98.39% of its industry peers.
- In the last couple of years the Operating Margin of IRMD has grown nicely.
- Looking at the Gross Margin, with a value of 77.07%, IRMD belongs to the top of the industry, outperforming 89.25% of the companies in the same industry.
- IRMD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 30.87% | ||
| PM (TTM) | 26.31% | ||
| GM | 77.07% |
OM growth 3Y8.49%
OM growth 5Y5.96%
PM growth 3Y5.58%
PM growth 5Y0.99%
GM growth 3Y0.12%
GM growth 5Y-0.04%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), IRMD is creating value.
- IRMD has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, IRMD has more shares outstanding
- There is no outstanding debt for IRMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- An Altman-Z score of 51.42 indicates that IRMD is not in any danger for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 51.42, IRMD belongs to the top of the industry, outperforming 98.92% of the companies in the same industry.
- IRMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 51.42 |
ROIC/WACC1.93
WACC10%
2.3 Liquidity
- A Current Ratio of 6.64 indicates that IRMD has no problem at all paying its short term obligations.
- IRMD has a better Current ratio (6.64) than 84.95% of its industry peers.
- A Quick Ratio of 5.72 indicates that IRMD has no problem at all paying its short term obligations.
- The Quick ratio of IRMD (5.72) is better than 85.48% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.64 | ||
| Quick Ratio | 5.72 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 13.75% over the past year.
- IRMD shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 13.92% yearly.
- The Revenue has grown by 12.91% in the past year. This is quite good.
- The Revenue has been growing by 13.71% on average over the past years. This is quite good.
EPS 1Y (TTM)13.75%
EPS 3Y25.74%
EPS 5Y13.92%
EPS Q2Q%9.3%
Revenue 1Y (TTM)12.91%
Revenue growth 3Y20.55%
Revenue growth 5Y13.71%
Sales Q2Q%15.69%
3.2 Future
- Based on estimates for the next years, IRMD will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.26% on average per year.
- Based on estimates for the next years, IRMD will show a quite strong growth in Revenue. The Revenue will grow by 8.97% on average per year.
EPS Next Y15.29%
EPS Next 2Y14.48%
EPS Next 3Y9.26%
EPS Next 5YN/A
Revenue Next Year13.26%
Revenue Next 2Y11.69%
Revenue Next 3Y8.97%
Revenue Next 5YN/A
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 55.42, the valuation of IRMD can be described as expensive.
- IRMD's Price/Earnings ratio is a bit cheaper when compared to the industry. IRMD is cheaper than 68.28% of the companies in the same industry.
- IRMD is valuated expensively when we compare the Price/Earnings ratio to 27.21, which is the current average of the S&P500 Index.
- IRMD is valuated quite expensively with a Price/Forward Earnings ratio of 46.64.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of IRMD indicates a somewhat cheap valuation: IRMD is cheaper than 68.82% of the companies listed in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 24.26. IRMD is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 55.42 | ||
| Fwd PE | 46.64 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, IRMD is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
- 69.89% of the companies in the same industry are more expensive than IRMD, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 91.97 | ||
| EV/EBITDA | 48.97 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IRMD does not grow enough to justify the current Price/Earnings ratio.
- The excellent profitability rating of IRMD may justify a higher PE ratio.
PEG (NY)3.62
PEG (5Y)3.98
EPS Next 2Y14.48%
EPS Next 3Y9.26%
5. Dividend
5.1 Amount
- IRMD has a yearly dividend return of 0.65%, which is pretty low.
- Compared to an average industry Dividend Yield of 0.19, IRMD pays a better dividend. On top of this IRMD pays more dividend than 91.40% of the companies listed in the same industry.
- With a Dividend Yield of 0.65, IRMD pays less dividend than the S&P500 average, which is at 1.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.65% |
5.2 History
- IRMD has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 39.59% of the earnings are spent on dividend by IRMD. This is a low number and sustainable payout ratio.
DP39.59%
EPS Next 2Y14.48%
EPS Next 3Y9.26%
IRADIMED CORP / IRMD FAQ
Can you provide the ChartMill fundamental rating for IRADIMED CORP?
ChartMill assigns a fundamental rating of 7 / 10 to IRMD.
Can you provide the valuation status for IRADIMED CORP?
ChartMill assigns a valuation rating of 4 / 10 to IRADIMED CORP (IRMD). This can be considered as Fairly Valued.
Can you provide the profitability details for IRADIMED CORP?
IRADIMED CORP (IRMD) has a profitability rating of 9 / 10.
What are the PE and PB ratios of IRADIMED CORP (IRMD) stock?
The Price/Earnings (PE) ratio for IRADIMED CORP (IRMD) is 55.42 and the Price/Book (PB) ratio is 13.04.
Can you provide the financial health for IRMD stock?
The financial health rating of IRADIMED CORP (IRMD) is 9 / 10.